Prognostic value of Biomarkers around Transcatheter Aortic Valve Implantation

Prognostic value of Biomarkers around Transcatheter Aortic Valve Implantation - Biomarkers around TAVI

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON37864

Enrollment

300

Registered

2012-10-09

Start date

2012-10-15

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aortic valve narrowing aortic valve stenosis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: transcatheter aortic valve implantation

Exclusion criteria

Exclusion criteria: No additional exclusion criteria besides exclusion criteria for transcatheter aortic valve implantation are applicable for extra blood samples

Design outcomes

Primary

Measure	Time frame
The primary endpoint is to document the course of biomarkers around transcatheter aortic valve implantation.	—

Secondary

Measure	Time frame
The course of biomarkers will be correlated to short and long term clinical outcomes and change in left ventricular function after transcatheter aortic valve implantation, measured non-invasively with echocardiography and cardiac CT and MRI,	—

Countries

Netherlands

Outcome results